Related Experiment Video
Updated: Jun 15, 2026

Controllable Ion Channel Expression through Inducible Transient Transfection
Published on: February 17, 2017
(R)-roscovitine prolongs the mean open time of unitary N-type calcium channel currents
N R DeStefino1, A A Pilato, M Dittrich
1Department of Neuroscience, University of Pittsburgh, Pittsburgh, PA 15260, USA.
Abstract:
(R)-roscovitine (Ros) is a cyclin-dependent kinase inhibitor that also has been shown to have direct agonist and antagonist actions on Ca(v)2.1 (P/Q-type) and Ca(v) 2.2 (N-type) families of voltage-gated calcium channels. These kinase-independent effects represent a novel opportunity to advance our understanding of calcium channel function and calcium-triggered neurotransmitter release. Furthermore, such actions on calcium channels may direct the development of Ros derivatives as new therapeutic agents. We used patch clamp recordings to characterize mechanisms that underlie the agonist effects of Ros on unitary N-type calcium channel gating. We found that N-type channels normally gate with either a short or long mean open time, that Ros significantly prolonged the mean open time of the long gating component and increased the probability of observing channels that gated with a long open time, but had no effect on single channel conductance. Using Monte Carlo simulations of a single channel kinetic model and Ros interactions, we were able to reproduce our experimental results and investigate the model's microscopic dynamics. In particular, our simulations predicted that the longer open times generated by Ros were due to the appearance of a long open state combined with an increased amount of time spent in transitions between open states. Our results suggest a mechanism for agonist effects of Ros at the level of single channels, and provide a mechanistic explanation for previously reported agonist effects on whole cell calcium currents.
Insights
(R)-roscovitine (Ros) directly modulates N-type calcium channels, prolonging their open time and increasing channel activity. This provides a novel mechanism for understanding calcium channel function and developing new therapeutics.
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- (R)-roscovitine (Ros) is a cyclin-dependent kinase inhibitor.
- Ros exhibits kinase-independent agonist and antagonist actions on Ca(v)2.1 and Ca(v)2.2 calcium channels.
- These actions offer insights into calcium channel function and neurotransmitter release.
Purpose of the Study:
- To characterize the mechanisms underlying the agonist effects of Ros on N-type calcium channel gating.
- To investigate the impact of Ros on single N-type calcium channel behavior.
Main Methods:
- Patch clamp recordings were used to analyze unitary N-type calcium channel gating.
- Monte Carlo simulations of a single channel kinetic model were employed to study Ros interactions.
Main Results:
- Ros significantly prolonged the mean open time of the long gating component of N-type channels.
- Ros increased the probability of channels exhibiting long open times without affecting single channel conductance.
- Simulations predicted that Ros introduces a long open state and increases transitions between open states.
Conclusions:
- Ros acts as an agonist at the single-channel level by altering gating kinetics.
- The findings provide a mechanistic explanation for Ros's previously observed effects on whole-cell calcium currents.
- This study highlights the potential of Ros derivatives as therapeutic agents targeting calcium channels.
More Related Videos
10:01High-Throughput Optical Controlling and Recording Calcium Signal in iPSC-Derived Cardiomyocytes for Toxicity Testing and Phenotypic Drug Screening
Published on: March 31, 2022
09:35Preclinical Cardiac Electrophysiology Assessment by Dual Voltage and Calcium Optical Mapping of Human Organotypic Cardiac Slices
Published on: June 16, 2020
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.